April 4, 2022 Acad, Gov/Utilities Clinical Research/Diagn. Microscopy U.S. FDA grants priority review to Roche’s Actemra/RoActemra for the treatment of COVID-19 in hospitalised adults Read more
April 4, 2022 Licensing, IP, and Legal Product Launch New data for Roche’s OCREVUS (ocrelizumab) show benefit in disability progression and cognitive decline in both secondary progressive and primary progressive multiple sclerosis Read more
March 30, 2022 Bio/Pharma/CRO Ad hoc announcement pursuant to Art. 53 LR Roche provides update on phase III SKYSCRAPER-02 study in extensive-stage small cell lung cancer Read more
March 25, 2022 Uncategorized CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma Read more
March 25, 2022 Uncategorized Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting Read more
March 23, 2022 Clinical Research/Diagn. Roche donates additional medicines and diagnostics for Ukraine Read more
March 16, 2022 Uncategorized Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern Read more
March 16, 2022 Licensing, IP, and Legal Product Launch New data for Roche’s Evrysdi (risdiplam) demonstrate long-term efficacy and safety in a broad population of people with spinal muscular atrophy (SMA) Read more
March 8, 2022 Product Launch Roche to present new Evrysdi data at MDA 2022 and highlight expanding neuromuscular disease portfolio Read more